Article
A novel recessive 15-hydroxyprostaglandin dehydrogenase mutation in a family with primary hypertrophic osteoarthropathy.
Modern rheumatology - 1 Mar 2015
Erken Eren, Köroğlu Çiğdem, Yıldız Fatih, Özer Hüseyin T E, Gülek Bozkurt, Tolun Aslıhan
Abstract excerpt
We present two PHO siblings having a novel homozygous truncating mutation in HPGD. The purpose of the study was to attempt medical treatment, and to find the HPGD mutation causing the disease, in a 22-year old Turkish male and his 23-year old sister afflicted with primary hypertrophic osteoarthropathy (PHO). In combination with NSAIDs and colchicine, treatment with sulfasalazine was started in both cases, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
